ALL
54
-12
AMP
37
-6
XRAY
8
-3
LYB
6
-9
EQIX
43
-9
ROST
50
-5
HRB
50
-7
AMG
41
-8
VZ
39
-15
F
42
-4
LMT
20
-12
AVB
34
-8
KMX
48
-4
IRM
23
-11
SRE
30
-12
SHW
50
-8
GIS
37
-9
IFF
29
-7
CAT
27
-8
AKAM
21
-6
ALL
54
-12
AMP
37
-6
XRAY
8
-3
LYB
6
-9
EQIX
43
-9
ROST
50
-5
HRB
50
-7
AMG
41
-8
VZ
39
-15
F
42
-4
LMT
20
-12
AVB
34
-8
KMX
48
-4
IRM
23
-11
SRE
30
-12
SHW
50
-8
GIS
37
-9
IFF
29
-7
CAT
27
-8
AKAM
21
-6
Financhill
Back

Amedisys Stock Predictions

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48

AMED
Amedisys

Last Price:
$91.90
Seasonality Move:
7.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Amedisys Stock Forecast

  • Over the next 52 weeks, Amedisys has on average historically risen by 30.8% based on the past 30 years of stock performance.
  • Amedisys has risen higher in 20 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Amedisys Stock Undervalued?
    The current Amedisys [AMED] share price is $91.89. The Score for AMED is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • AMED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Amedisys Stock Go Up Next Year?

  • Over the next 52 weeks, Amedisys has on average historically risen by 30.8% based on the past 30 years of stock performance.

Amedisys Stock Rating

Sell
48
Amedisys (AMED) is a Sell

Is Amedisys overpriced?

  • Amedisys has risen higher in 20 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Amedisys Stock Price History

Is AMED stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMED is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
amedisys.com

52-Week Data

52-Week High:
98.95
52-Week Low:
82.15

Prediction Charts

Market Cap:
3B
Price in USD:
91.89
Volume:
489.2K
Beta:
0.60

Technical Analysis

SMA50:
92.34
SMA100:
90.92
SMA200:
93.78
52-Wk Change:
-0.98%

Stock Predictions

  • Is Amedisys stock public?
    Yes, Amedisys is a publicly traded company.
  • What is the Amedisys stock quote today?
    The Amedisys stock price is 91.89 USD today.
  • How to buy Amedisys stock online?
    You can buy Amedisys shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-18 92.70 92.50 92.92 92.49
Mar-19 92.64 92.89 93.00 92.54
Mar-20 92.60 92.77 93.09 92.31
Mar-21 92.72 92.40 92.86 91.32
Mar-24 92.63 92.74 92.97 92.05
Mar-25 92.63 92.36 92.71 92.15
Mar-26 92.54 92.43 92.54 92.16
Mar-27 92.65 92.90 92.98 92.47
Mar-28 92.98 92.70 92.99 92.65
Mar-31 92.60 92.63 93.25 92.44
Apr-1 92.36 92.84 93.03 91.48
Apr-2 92.51 92.98 93.25 92.27
Apr-3 92.51 92.99 93.25 92.48
Apr-4 92.59 91.89 92.99 91.69

Amedisys Earnings

Amedisys Earnings Report: Per Share Amedisys Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amedisys Forecast Revenue Growth

Amedisys Stock Analysis: Historical quarterly revenues per share for Amedisys and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.35 per share, and an increase next year of $0.42 per share.

* Amedisys stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.